Titlebook: Assessment of Cancer Screening; A Primer Pamela M. Marcus Book‘‘‘‘‘‘‘‘ 2022 National Institutes of Health, Cancer Control and Population Sc

斗爭

Performance Measures,e calculated from sensitivity and false positive rate, are presented as well. Additional aspects of performance measures, including the role of disease prevalence in cancer screening test performance (in particular, the impact on positive predictive value), are discussed.

overture

Experimental Research Designs, minimizes the possibility of confounding. In the context of cancer screening, confounding occurs when a third factor is related to both screening activity and cause-specific mortality. Individual-level, cluster-level, and pragmatic RCTs are discussed in detail. Examples of each are provided.

自戀

trigger

cunning

Eructation

Foundations,lear thinking, an open mind, and knowledge of a small set of foundational concepts, which are presented in this chapter. Cancer screening, the routine, periodic testing for signs of cancer among individuals who have no symptoms, is explained and its goals, at both an individual and population level,

Desert

貪婪地吃

blackout

反省